Cytokine profiles in drug-naive schizophrenic patients

Schizophrenia Research

Volumn 47, Issue 2-3, 2001, Pages 293-298

  Cazzullo, C L ^a   Sacchetti, E ^b   Galluzzo, A ^b   Panariello, A ^b   Colombo, F ^c   Zagliani, A ^c   Clerici, M ^c  

^a Fondazione Legrenzi   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 4;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOLOGY; MALE; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; SCHIZOPHRENIA;

ADULT; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; SCHIZOPHRENIA;

EID: 0035280976     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(00)00046-3     Document Type: Article

References (27)

1. Cytokine production in drug-free and neuroleptic treated schizophrenic patients
2. Immunology of schizophrenia
3. +lymphocytes in schizophrenia patients
4. Cytokines production in chronic schizophrenia patients with or without paranoid behaviour
5. An analysis of lymphocyte subpopulations in schizophrenic patients
6. The neuropsychiatric effects of treatment with Interleukin-2 and lymphokine-activated killer cells
7. Increased serum Interleukin 2 receptor levels in schizophrenic and brain damaged subjects
8. Clinical and laboratory evidence of autoimmunity in acute schizophrenia
9. Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness
10. T-lymphocyte subpopulations in schizophrenic patients
11. Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia
12. Decreased interleukin-2 production in Korean schizophrenic patients
13. Elevated levels of Interleukin-2 in neuroleptic-free schizophrenics
14. A new five-factor model of schizophrenia
15. Immune-inflammatory markers in schizophrenis: Comparison to normal controls and effects of clozapine
16. Lymphocyte subsets in schizophrenic disorders
17. Cellular immunity, HLA-class I antigens, and family history of psychiatric disorder in endogenous psychoses
18. Scenarios for viral etiology of schizophrenia
19. The central nervous system-immune system relationship
20. Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia
21. Increased soluble Interleukin-2 receptors in Caucasian and Korean schizophrenic patients
22. Elevated levels of soluble interleukin-2 receptors in schizophrenia
23. Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins
24. Immunological dysfunction in schizophrenia: A systematic approach
25. T-cell subsets in schizophrenia: A comparison between drug-naive first episode patients and chronic schizophrenic patients
26. Aberrant T-cell mediated immunity in untreated schizophrenic patients: Deficient Interleukin-2 production
27. Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients